An experimental vaccine from Moderna has prevented the return and spread of cancer in high-risk melanoma patients. The company’s shares surged more than 175% ... Show more
Similar to This
Previous
Paid articlePaywall Moderna Earnings Preview: The Melanoma Breakthrough Is Real, But $221 Is Way Too Much
seekingalpha.com/article/4962734-moderna-earnings-preview-the-melanoma-breakthrough-is-real-but-221-is-way-too-much
WIRED Oct 24
New mRNA Vaccine Reduces Risk of Melanoma Recurrence by Over 40 Percent: The vaccine is personalized to a patient’s tumor, and results from the Phase 3 trial are ...
wired.com/story/new-melanoma-vaccine-reduces-risk-of-tumor-reoccurrence-by-over-40-percent/
Merck CEO expects personalized cancer vaccine to be made faster over time: Rob Davis told CNBC the six-week timeline from tumor sequencing to hospital delivery ...
qz.com/merck-ceo-davis-cancer-vaccine-manufacturing-faster-101426
Moderna, Merck breakthrough could usher in cancer vaccines: The companies said their vaccine helped prevent the return and spread of melanoma in a trial that ...
omaha.com/news/nation-world/science/article_76bed75e-1dbd-5e01-ba4e-b380728df92d.html
Nature Aug 20
Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?
nature.com/articles/d41586-026-02612-3
Moderna-Merck melanoma therapy averts cancer recurrence in study: A personalized vaccine developed by Moderna Inc. and Merck & Co. helped reduce the recurrence ...
chicagotribune.com/2026/08/19/moderna-merck-melanoma-cancer/
Moderna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer
scientificamerican.com/article/moderna-and-merck-announce-landmark-trial-showing-mrna-therapy-significantly-cuts-odds-of-recurrent-skin-cancer/
CNA Aug 21
CNA Explains: What we know about the Moderna, Merck breakthrough cancer vaccine: The personalised vaccine has succeeded in a final-stage melanoma trial ...
channelnewsasia.com/world/moderna-merck-mrna-cancer-vaccine-breakthrough-6333371
Moderna says skin cancer vaccine trial a success: The experimental vaccine successfully reduced the recurrence of melanoma, the company said
theweek.com/health/moderna-says-skin-cancer-vaccine-success
STAT Aug 19
Paid articlePaywall Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial: The personalized mRNA cancer vaccine, added to Merck's Keytruda ...
statnews.com/2026/08/19/mrna-cancer-vaccine-trial-melanoma-merck-moderna/
‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial: The drug is based on the same messenger RNA (mRNA) technology behind Covid-19 vaccines ...
straitstimes.com/world/united-states/breakthrough-mrna-cancer-drug-curbs-melanoma-in-large-trial
Skin cancer breakthrough after experimental mRNA drug found to prevent disease returning
independent.co.uk/news/health/mrna-drug-skin-cancer-trial-merck-moderna-vaccine-b3035615.html
Cancer therapy: Moderna reports positive results in study of skin cancer vaccine: Moderna has published positive study data on a novel melanoma vaccine ...
zeit.de/gesundheit/2026-08/mrna-krebsimpfstoff-moderna-merck-intismeran-keytruda-melanom
Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread: Moderna’s mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in ...
aljazeera.com/news/2026/8/19/moderna-merck-unveil-mrna-based-cancer-vaccine-that-cuts-spread
Moderna, Merck breakthrough could usher in wave of cancer vaccines: Unlike chemotherapy, which kills both healthy and cancerous cells, or immunotherapy ...
rappler.com/science/life-health/moderna-merck-breakthrough-cancer-vaccines/
Moderna shares soar 150% after personalised cancer vaccine breakthrough: The vaccine is currently being studied on melanoma, which is responsible for about 1 per ...
indianexpress.com/article/world/moderna-merck-personalised-mrna-melanoma-cancer-vaccine-10840762/
Paid articlePaywall mRNA vaccine against cancer: Is the breakthrough imminent?: A vaccine from Moderna halves the risk of relapse in melanoma in a five-year study.
sueddeutsche.de/gesundheit/hautkrebs-mrna-impfstoff-li.3487705
Moderna CEO hails breakthrough mRNA cancer vaccine that halves melanoma recurrence risk with Keytruda
foxbusiness.com/media/moderna-ceo-hails-breakthrough-mrna-cancer-vaccine-halves-melanoma-recurrence-risk-keytruda
Against melanoma: Moderna study raises hopes for the world's first mRNA cancer vaccine
spiegel.de/wissenschaft/moderna-studie-weckt-hoffnungen-auf-den-weltweit-ersten-krebsimpfstoff-a-17e888bf-5b75-4688-a6b4-61b631db382f
Key FactsHope for mRNA Cancer Vaccine: Moderna Study on Melanoma
Jun 3, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: spiegel.de
Summary created with AI assistance · Source: spiegel.de
- Moderna presents promising study results at cancer conference.
- Innovative mRNA vaccine intended to combat high-risk melanoma.
- Long-term efficacy of the vaccine in skin cancer demonstrated.
- Moderna aims for expedited approval of mRNA-4157 by 2025.
Moderna’s mRNA cancer vaccine trial is ‘big step forward,’ Cambridge biotech’s stock surges 25%
bostonherald.com/2022/12/13/modernas-mrna-cancer-vaccine-trial-is-big-step-forward-cambridge-biotechs-stock-surges-25/
Next